Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
The VaDDC Executive Committee is pleased to announce the VirginiaDrugDiscoveryRx: Emerging Targets, Technologies, and Therapeutics for Cancer and Neuroscience meeting will be held at the
Hotel Roanoke – May 21, 22, 2019
⇒ At least 4 Poster prizes will be presented at the Symposium. See the event registration page for details.
Thank you to our sponsors whose participation in the
VirginiaDrugDiscoveryRx: Emerging Targets,Technologies, and Therapeutics Symposium
to be held at the
Hotel Roanoke, May 21-22, 2019
is key to the meeting’s success.
- Medicines for All Institute – VCU
- Carilion Clinic
- City of Roanoke Department of Economic Development
- University of Virginia – Licensing & Ventures Group
- University of Virginia – Brain Institute
- University of Virginia – Cancer Center
- Virginia Biosciences Health Research Corporation
- Virginia Commonwealth University – Innovation Gateway
- Virginia Commonwealth University – Massey Cancer Center
- Virginia Tech – LINK
- Virginia Tech – Outreach & International Affairs
- Woods Rogers PLC
- New River Valley IP Law
Webster Santos – VT and Kevin Lynch-UVA received a $2.8 NIAID grant to Develop a Drug to Treat Multiple Sclerosis
Santos received this research grant in collaboration with Kevin Lynch, a professor of pharmacology at the University of Virginia. Lynch will oversee the biological testing of the drug. The NIAID award builds on an existing research grant from the National Institute of...read more
The integrated Translational Health Research Institute of Virginia (iTHRIV) has been awarded a five-year grant of nearly $23 million from the National Institutes of Health (NIH) to advance innovative ideas from the point of discovery to implementation in clinical...read more
The Desai lab has received the “Glycans in Blood Homeostasis and Disease” grant. This is a five-year K12 grant by National Heart, Lung and Blood Institute to train MDs, PhDs and dual degree holders for advanced careers in glycosciences. Only four such K12 grants were...read more
Want to work with us?
If you are interested in supporting this initiative, please contact us.